Add to ORKGBAFF inhibition does not significantly impair immunization responses in patients with rheumatoid arthritis in start. A study flow chart shows this in more detail treated patients had similar responses as placebo in the development of total pneumococcal IgG (twofold or sponse to protein or polysaccharide vaccines in R
Rituximab (RTX) treatment in rheumatoid arthritis (RA) patients severely hampers humoral response af...
Rituximab (RTX) treatment in rheumatoid arthritis (RA) patients severely hampers humoral response af...
Rituximab (RTX) treatment in rheumatoid arthritis (RA) patients severely hampers humoral response af...
BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response t...
Objective. To compare antibody responses to 23-valent pneumococcal vaccine (Pneumovax (R)) in contro...
Objective: Vaccination is a key strategy to reduce infection risk in patients with rheumatoid arthri...
Background: Pneumococcal vaccination is recommended to patients with rheumatoid arthritis (RA) and p...
The objectives of the study were to compare antibody response in immunosuppressed patients with rheu...
a b s t r a c t Patients with rheumatoid arthritis (RA) are at increased risk of infection compared...
We investigated B-cell-activating factor (BAFF) in relation to response to treatment with TNF inhibi...
Rituximab (RTX) treatment in rheumatoid arthritis (RA) patients severely hampers humoral response af...
Rituximab (RTX) treatment in rheumatoid arthritis (RA) patients severely hampers humoral response af...
Abstract Background Pneumococcal vaccination is recommended to patients with rheumatoid arthritis (R...
ABSTRACT. Objective. This study compared the immunogenicity of influenza and pneumococcal vaccines i...
Rituximab (RTX) treatment in rheumatoid arthritis (RA) patients severely hampers humoral response af...
Rituximab (RTX) treatment in rheumatoid arthritis (RA) patients severely hampers humoral response af...
Rituximab (RTX) treatment in rheumatoid arthritis (RA) patients severely hampers humoral response af...
Rituximab (RTX) treatment in rheumatoid arthritis (RA) patients severely hampers humoral response af...
BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response t...
Objective. To compare antibody responses to 23-valent pneumococcal vaccine (Pneumovax (R)) in contro...
Objective: Vaccination is a key strategy to reduce infection risk in patients with rheumatoid arthri...
Background: Pneumococcal vaccination is recommended to patients with rheumatoid arthritis (RA) and p...
The objectives of the study were to compare antibody response in immunosuppressed patients with rheu...
a b s t r a c t Patients with rheumatoid arthritis (RA) are at increased risk of infection compared...
We investigated B-cell-activating factor (BAFF) in relation to response to treatment with TNF inhibi...
Rituximab (RTX) treatment in rheumatoid arthritis (RA) patients severely hampers humoral response af...
Rituximab (RTX) treatment in rheumatoid arthritis (RA) patients severely hampers humoral response af...
Abstract Background Pneumococcal vaccination is recommended to patients with rheumatoid arthritis (R...
ABSTRACT. Objective. This study compared the immunogenicity of influenza and pneumococcal vaccines i...
Rituximab (RTX) treatment in rheumatoid arthritis (RA) patients severely hampers humoral response af...
Rituximab (RTX) treatment in rheumatoid arthritis (RA) patients severely hampers humoral response af...
Rituximab (RTX) treatment in rheumatoid arthritis (RA) patients severely hampers humoral response af...
Rituximab (RTX) treatment in rheumatoid arthritis (RA) patients severely hampers humoral response af...